The FDA is concerned about misuse and overreliance of rupture of amniotic membrane lab test results without other clinical assessments to make patient management decisions, which could lead to serious harm.
News Alerts …read more
The FDA is concerned about misuse and overreliance of rupture of amniotic membrane lab test results without other clinical assessments to make patient management decisions, which could lead to serious harm.
News Alerts …read more
Comments are closed.
Nice posts! 🙂
___
Sanny
http://afcmarseille.com